1
|
Gianferante DM, Mirabello L and Savage SA:
Germline and somatic genetics of osteosarcoma-connecting aetiology,
biology and therapy. Nat Rev Endocrinol. 13:480–491. 2017.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Colding-Rasmussen T, Thorn AP, Horstmann
P, Rechnitzer C, Hjalgrim LL, Krarup-Hansen A and Petersen MM:
Survival and prognostic factors at time of diagnosis in high-grade
appendicular osteosarcoma. Acta Oncol. 57:420–425. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kansara M, Teng MW, Smyth MJ and Thomas
DM: Translational biology of osteosarcoma. Nat Rev Cancer.
14:722–735. 2014. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Vos HI, Coenen MJ, Guchelaar HJ and Te Loo
DM: The role of pharmacogenetics in the treatment of osteosarcoma.
Drug Discov Today. 21:1775–1786. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Xie L, Yao Z, Zhang Y, Li D, Hu F, Liao Y,
Zhou L, Zhou Y, Huang Z, He Z, et al: Deep RNA sequencing reveals
the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma
tumorigenesis and pulmonary metastasis. Cell Death Dis. 9:7722018.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Ma J, Huang K, Ma Y, Zhou M and Fan S: The
TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma. Cell
Death Dis. 8:e25392017. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ji Q, Xu X, Li L, Goodman SB, Bi W, Xu M,
Xu Y, Fan Z, Maloney WJ, Ye Q and Wang Y: miR-216a inhibits
osteosarcoma cell proliferation, invasion and metastasis by
targeting CDK14. Cell Death Dis. 8:e31032017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Raza U, Zhang JD and Sahin O: MicroRNAs:
Master regulators of drug resistance, stemness, and metastasis. J
Mol Med (Berl). 92:321–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang C, Jing J and Cheng L: Emerging roles
of non-coding RNAs in the pathogenesis, diagnosis and prognosis of
osteosarcoma. Invest New Drugs. 36:1116–1132. 2018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Su P, Mu S and Wang Z: Long noncoding RNA
SNHG16 promotes osteosarcoma cells migration and invasion via
sponging miR-340. DNA Cell Biol. 38:170–175. 2019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pu Y, Zhao F, Cai W, Meng X, Li Y and Cai
S: miR-193a-3p and miR-193a-5p suppress the metastasis of human
osteosarcoma cells by downregulating Rab27B and SRR, respectively.
Clin Exp Metastasis. 33:359–372. 2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yan W, Yang W, Liu Z and Wu G:
Characterization of microRNA expression in primary human colon
adenocarcinoma cells (SW480) and their lymph node metastatic
derivatives (SW620). OncoTargets Ther. 11:4701–4709. 2018.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Li C, Wang M, Wang Y, Zhang J and Sun N: A
new model of the mechanism underlying lead poisoning: SNPs in miRNA
target region influence the delta-aminolevulinic acid dehydratase
expression level. Epigenomics. 9:1353–1361. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Bergdahl IA, Grubb A, Schutz A, Desnick
RJ, Wetmur JG, Sassa S and Skerfving S: Lead binding to
delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes.
Pharmacol Toxicol. 81:153–158. 1997. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wang C, Han XS, Li FF, Huang S, Qin YW,
Zhao XX and Jing Q: Forkhead containing transcription factor Albino
controls tetrapyrrole-based body pigmentation in planarian. Cell
Discov. 2:160292016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y,
Jia Y, Li Q, Zhang H, Tu K, et al: Ftx non coding RNA-derived
miR-545 promotes cell proliferation by targeting RIG-I in
hepatocellular carcinoma. Oncotarget. 7:25350–25365. 2016.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Hu C, Wang Y, Li A, Zhang J, Xue F and Zhu
L: Overexpressed circ_0067934 acts as an oncogene to facilitate
cervical cancer progression via the miR-545/EIF3C axis. J Cell
Physiol. 234:9225–9232. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yuan G, Wu H, Du Y and He F: Tumor
suppressor role of microRNA-545 in oral squamous cell carcinoma.
Oncol Lett. 17:2063–2068. 2019.PubMed/NCBI
|
21
|
Miao Z, Liu S, Xiao X and Li D: LINC00342
regulates cell proliferation, apoptosis, migration and invasion in
colon adenocarcinoma via miR-545-5p/MDM2 axis. Gene.
743:1446042020. View Article : Google Scholar : PubMed/NCBI
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Lu YF, Yu JR, Yang Z, Zhu GX, Gao P, Wang
H, Chen SY, Zhang J, Liu MY, Niu Y, et al: Promoter hypomethylation
mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote
the progression of esophageal squamous cell carcinoma (ESCC). J Exp
Clin Cancer Res. 37:3012018. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nunes JPS and Dias AAM: ImageJ macros for
the user-friendly analysis of soft-agar and wound-healing assays.
Biotechniques. 62:175–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Marshall J: Transwell (®)
invasion assays. Methods Mol Biol. 769:97–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chen X, Cao X, Sun X, Lei R, Chen P, Zhao
Y, Jiang Y, Yin J, Chen R, Ye D, et al: Bcl-3 regulates TGFbeta
signaling by stabilizing Smad3 during breast cancer pulmonary
metastasis. Cell Death Dis. 7:e25082016. View Article : Google Scholar : PubMed/NCBI
|
27
|
National Research Council, . National
Institutes of Health Guide for the Care and Use of Laboratory
Animals: 8th Edition. The National Academies Press; Washington, DC:
2011
|
28
|
Laferriere CA and Pang DS: Review of
intraperitoneal injection of sodium pentobarbital as a method of
euthanasia in laboratory rodents. J Am Assoc Lab Anim Sci.
59:254–263. 2020. View Article : Google Scholar : PubMed/NCBI
|
29
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yu AM, Jian C, Yu AH and Tu MJ: RNA
therapy: Are we using the right molecules? Pharmacol Ther.
196:91–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
31
|
Nugent M: microRNA and bone cancer. Adv
Exp Med Biol. 889:201–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Xie M, Ma L, Xu T, Pan Y, Wang Q, Wei Y
and Shu Y: Potential regulatory roles of MicroRNAs and long
noncoding RNAs in anticancer therapies. Mol Ther Nucleic Acids.
13:233–243. 2018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhang H, Zhang K, Xu Z, Xu Z, Chen Z, Wang
Q, Wang C and Cui J: MicroRNA-545 suppresses progression of ovarian
cancer through mediating PLK1 expression by a direct binding and an
direct regulation involving KDM4B-mediated demethylation. BMC
Cancer. 21:1632021. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ikeda S, Kitadate A, Abe F, Saitoh H,
Michishita Y, Hatano Y, Kawabata Y, Kitabayashi A, Teshima K, Kume
M, et al: Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4
oncogenic axis in multiple myeloma. Cancer Sci. 108:641–652. 2017.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Liu G, Peng X, Cai Y, Cheng A, Zha L and
Wang Z: DIMT1 overexpression correlates with progression and
prognosis in gastric carcinoma. Hum Pathol. 70:35–42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Kiga K, Mimuro H, Suzuki M,
Shinozaki-Ushiku A, Kobayashi T, Sanada T, Kim M, Ogawa M, Iwasaki
YW, Kayo H, et al: Epigenetic silencing of miR-210 increases the
proliferation of gastric epithelium during chronic Helicobacter
pylori infection. Nat Commun. 5:44972014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Guo ZX, Zhou FZ, Song W, Yu LL, Yan WJ,
Yin LH, Sang H and Zhang HY: Suppression of microRNA-101 attenuates
hypoxia-induced myocardial H9c2 cell injury by targeting
DIMT1-Sp1/survivin pathway. Eur Rev Med Pharmacol Sci.
22:6965–6976. 2018.PubMed/NCBI
|